Free Trial

Tyra Biosciences (TYRA) Short Interest Ratio & Short Volume

Tyra Biosciences logo
$8.30 -0.35 (-4.05%)
Closing price 04:00 PM Eastern
Extended Trading
$8.29 -0.01 (-0.12%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tyra Biosciences Short Interest Data

Tyra Biosciences (TYRA) has a short interest of 3.92 million shares, representing 12.23% of the float (the number of shares available for trading by the public). This marks a -3.92% decrease in short interest from the previous month. The short interest ratio (days to cover) is 14.1, indicating that it would take 14.1 days of the average trading volume of 296,266 shares to cover all short positions.

Current Short Interest
3,920,000 shares
Previous Short Interest
4,080,000 shares
Change Vs. Previous Month
-3.92%
Dollar Volume Sold Short
$45.08 million
Short Interest Ratio
14.1 Days to Cover
Last Record Date
March 15, 2025
Outstanding Shares
50,603,000 shares
Float Size
32,040,000 shares
Short Percent of Float
12.23%
Today's Trading Volume
368,384 shares
Average Trading Volume
296,266 shares
Today's Volume Vs. Average
124%
Short Selling Tyra Biosciences?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Tyra Biosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

TYRA Short Interest Over Time

TYRA Days to Cover Over Time

TYRA Percentage of Float Shorted Over Time

Remove Ads

Tyra Biosciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/15/20253,920,000 shares $45.08 million -3.9%12.2%14.1 $11.50
2/28/20254,080,000 shares $47.78 million +10.9%12.7%15.7 $11.71
2/15/20253,680,000 shares $48.54 million +30.5%11.9%15.7 $13.19
1/31/20252,820,000 shares $40.78 million +1.8%9.2%11 $14.46
1/15/20252,770,000 shares $46.34 million +9.1%9.0%8 $16.73
12/31/20242,540,000 shares $35.31 million +0.4%8.3%7.4 $13.90
12/15/20242,530,000 shares $37.80 million +25.9%8.2%7.7 $14.94
11/30/20242,010,000 shares $31.52 million +7.5%6.8%6.1 $15.68
11/15/20241,870,000 shares $28.78 million +6.3%6.3%5.9 $15.39
10/31/20241,760,000 shares $29.36 million -20.0%6.1%6 $16.68
10/15/20242,200,000 shares $53.81 million -7.6%8.3%12 $24.46
9/30/20242,380,000 shares $55.95 million -0.8%8.9%15.4 $23.51
9/15/20242,400,000 shares $50.98 million +6.2%9.0%13.8 $21.24
8/31/20242,260,000 shares $51.44 million +2.3%8.5%13.8 $22.76
8/15/20242,210,000 shares $48.62 million -0.5%8.4%13 $22.00
7/31/20242,220,000 shares $49.20 million +0.5%8.3%13.5 $22.16
7/15/20242,210,000 shares $44.35 million +12.2%8.3%14.4 $20.07
6/30/20241,970,000 shares $31.50 million +3.8%7.4%12.6 $15.99
6/15/20241,897,500 shares $36.89 million -3.2%7.1%13.2 $19.44
5/31/20241,960,000 shares $31.79 million -4.4%7.4%13.2 $16.22
5/15/20242,050,000 shares $37.80 million -40.4%7.7%15.7 $18.44
4/30/20243,440,000 shares $58.82 million +5.2%11.0%26.5 $17.10
4/15/20243,270,000 shares $48.23 million +15.6%13.8%23.4 $14.75
3/31/20242,830,000 shares $46.41 million +8.9%14.9%21 $16.40
3/15/20242,600,000 shares $45.50 million +7.4%13.9%20.6 $17.50
2/29/20242,420,000 shares $48.38 million +6.6%13.0%21.4 $19.99
2/15/20242,270,000 shares $43.13 million +11.3%12.2%21.4 $19.00
1/31/20242,040,000 shares $27.34 million +8.5%10.8%20.4 $13.40
1/15/20241,880,000 shares $24.08 million +30.6%10.1%23.4 $12.81
12/31/20231,440,000 shares $19.94 million -7.1%N/A18.1 $13.85
12/15/20231,550,000 shares $20.93 million -7.2%8.4%20.1 $13.50
11/30/20231,670,000 shares $19.56 million +0.6%9.1%26.4 $11.71
11/15/20231,660,000 shares $20.53 million -6.7%9.0%26.9 $12.37
10/31/20231,780,000 shares $20.65 million +6.6%9.5%29.9 $11.60
10/15/20231,670,000 shares $23.61 million -6.2%8.9%30.5 $14.14
9/30/20231,780,000 shares $24.51 million -4.3%9.5%34.8 $13.77
9/15/20231,860,000 shares $27.36 million +3.3%9.9%29.3 $14.71
8/31/20231,800,000 shares $27.41 million +1.1%9.7%22.9 $15.23
8/15/20231,780,000 shares $27.59 million +6.0%9.6%22.7 $15.50
7/31/20231,680,000 shares $24.90 million +5.0%9.3%22.1 $14.82
DOGE tax surprise (Ad)

Elon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax authorities have bought a powerful new AI supercomputer, worth millions of dollars. It's the most advanced technology offered by AI giant Nvidia. And it's almost certainly going to be used to advance Elon Musk's real agenda with DOGE... the massive, rapid roll out of AI across the entire federal government.

Move now and you could get in first - with huge upside potential.
7/15/20231,600,000 shares $23.39 million +1.3%8.9%22.4 $14.62
6/30/20231,580,000 shares $26.91 million +9.0%8.8%23.8 $17.03
6/15/20231,450,000 shares $23.20 million -1.4%8.1%28 $16.00
5/31/20231,470,000 shares $21.27 million +2.8%8.3%47 $14.47
5/15/20231,430,000 shares $18.85 million -0.7%8.0%41.7 $13.18
4/30/20231,440,000 shares $20.40 million +0.7%8.0%28.4 $14.17
4/15/20231,430,000 shares $21.08 million +3.6%8.0%27.1 $14.74
3/31/20231,380,000 shares $22.18 million +7.0%7.8%26.1 $16.07
3/15/20231,290,000 shares $18.33 million +6.6%6.6%25.3 $14.21
2/28/20231,210,000 shares $15.98 million No Change6.2%24.2 $13.21
2/15/20231,210,000 shares $15.10 million -0.8%6.2%21.5 $12.48
1/31/20231,220,000 shares $12.96 million No Change6.2%26.9 $10.62
1/15/20231,220,000 shares $10.24 million -3.9%6.2%26.6 $8.39
12/30/20221,270,000 shares $9.65 million -14.8%6.5%26.5 $7.60
12/15/20221,490,000 shares $9.42 million -2.6%7.6%28.8 $6.32
11/30/20221,530,000 shares $10.73 million -1.3%7.9%31 $7.01
11/15/20221,550,000 shares $11.61 million -6.1%8.0%29.1 $7.49
10/31/20221,650,000 shares $11.42 million -2.4%8.5%39 $6.92
10/15/20221,690,000 shares $11.37 million -2.3%8.8%43.1 $6.73
9/30/20221,730,000 shares $15.21 million +1.2%9.0%41.7 $8.79
9/15/20221,710,000 shares $15.41 million -0.6%8.9%33.8 $9.01
8/31/20221,720,000 shares $11.37 million -8.5%8.9%32.3 $6.61
8/15/20221,880,000 shares $22.47 million -1.6%9.7%33.4 $11.95
7/31/20221,910,000 shares $20.34 million No Change9.8%32.8 $10.65
7/15/20221,910,000 shares $18.43 million -1.6%9.8%29.6 $9.65
6/30/20221,940,000 shares $13.87 million -1.0%10.0%28.9 $7.15
6/15/20221,960,000 shares $11.52 million +1.6%10.1%28.1 $5.88
5/31/20221,930,000 shares $13.18 million -2.5%9.9%23.1 $6.83
5/15/20221,980,000 shares $15.33 million -4.8%10.2%21.2 $7.74
4/30/20222,080,000 shares $15.54 million -8.0%10.6%21.1 $7.47
4/15/20222,260,000 shares $22.33 million -0.9%11.6%20.7 $9.88
3/31/20222,280,000 shares $24.40 million -2.6%11.8%19.8 $10.70
3/15/20222,340,000 shares $23.47 million +15.8%12.2%16.8 $10.03
2/28/20222,020,000 shares $23.94 million +6.3%10.5%10.6 $11.85
2/15/20221,900,000 shares $23.88 million -2.1%9.9%9.8 $12.57
1/31/20221,940,000 shares $25.43 million +7.2%10.3%9.9 $13.11
1/15/20221,810,000 shares $22.55 million +5.2%9.6%9 $12.46
12/31/20211,720,000 shares $24.20 million No Change9.1%8.3 $14.07

TYRA Short Interest - Frequently Asked Questions

What is Tyra Biosciences' current short interest?

Short interest is the volume of Tyra Biosciences shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 3,920,000 shares of TYRA short. 12.23% of Tyra Biosciences' shares are currently sold short. Learn More on Tyra Biosciences' current short interest.

What is a good short interest ratio for Tyra Biosciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TYRA shares currently have a short interest ratio of 14.0. Learn More on Tyra Biosciences's short interest ratio.

Which institutional investors are shorting Tyra Biosciences?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Tyra Biosciences: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Tyra Biosciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.23% of Tyra Biosciences' floating shares are currently sold short.

Is Tyra Biosciences' short interest increasing or decreasing?

Tyra Biosciences saw a drop in short interest during the month of March. As of March 15th, there was short interest totaling 3,920,000 shares, a drop of 3.9% from the previous total of 4,080,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Tyra Biosciences' float size?

Tyra Biosciences currently has issued a total of 50,603,000 shares. Some of Tyra Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Tyra Biosciences currently has a public float of 32,040,000 shares.

How does Tyra Biosciences' short interest compare to its competitors?

12.23% of Tyra Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Tyra Biosciences: Denali Therapeutics Inc. (8.36%), Belite Bio, Inc (0.32%), Arrowhead Pharmaceuticals, Inc. (8.65%), Arcutis Biotherapeutics, Inc. (14.26%), Tarsus Pharmaceuticals, Inc. (21.10%), Harmony Biosciences Holdings, Inc. (9.45%), Travere Therapeutics, Inc. (14.90%), Janux Therapeutics, Inc. (21.18%), Disc Medicine, Inc. (10.29%), Agios Pharmaceuticals, Inc. (6.16%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks.

What does it mean to sell short Tyra Biosciences stock?

Short selling TYRA is an investing strategy that aims to generate trading profit from Tyra Biosciences as its price is falling. TYRA shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Tyra Biosciences?

A short squeeze for Tyra Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TYRA, which in turn drives the price of the stock up even further.

How often is Tyra Biosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TYRA, twice per month. The most recent reporting period available is March, 15 2025.




This page (NASDAQ:TYRA) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners